• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

66岁及以上医疗保险参保个体肺癌脑转移诊断后疾病相关不良事件的性别差异

Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.

作者信息

Dmukauskas Mantas, Cioffi Gino, Waite Kristin A, Mammoser Aaron G, Sloan Andrew E, Ma Patrick C, Barnholtz-Sloan Jill S

机构信息

Trans Divisional Research Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA.

Neuroscience Service Line and Piedmont Brain Tumor Center, Piedmont Health, Atlanta, GA 30309, USA.

出版信息

Cancers (Basel). 2024 Aug 28;16(17):2986. doi: 10.3390/cancers16172986.

DOI:10.3390/cancers16172986
PMID:39272844
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11394199/
Abstract

Sex differences are evident in adverse events (AEs) related to brain tumors, yet sex differences in AEs specific to brain metastases (BrMs) are underexplored. Lung cancer BrMs dominate among BrM, comprising over half of cases. This study examined sex differences in AEs associated with lung cancer BrMs in individuals aged 66 or older using the SEER-Medicare dataset. Multivariable logistic regression, adjusted for demographic factors and comorbidities, stratified by histological subtype, treatment, age, and year of diagnosis were used to analyze AEs among those with BrMs from primary lung tumors. Year of diagnosis was grouped into prior/post-2013, to account for shifts in treatment paradigms. The results showed nuanced sex-specific AEs. Females diagnosed post-2013 with small-cell, squamous-cell, or other non-small-cell carcinoma BrMs had a higher headache likelihood than males. Males with adenocarcinoma post-2013 were more likely to experience brain herniation. Females aged 76 and older with small-cell BrM exhibited increased vision difficulty risk compared to males of the same age, with no significant difference in other age groups. Males treated for adenocarcinoma faced heightened hemorrhagic stroke risk. This study reveals sex-specific disparities in AEs among older individuals with lung cancer BrMs, varying by histological subtype, age, diagnosis year, and treatment.

摘要

与脑肿瘤相关的不良事件(AE)中存在明显的性别差异,但脑转移瘤(BrM)特有的不良事件中的性别差异尚未得到充分研究。在脑转移瘤中,肺癌脑转移瘤占主导地位,占病例的一半以上。本研究使用SEER - 医疗保险数据集,调查了66岁及以上个体中与肺癌脑转移瘤相关的不良事件中的性别差异。采用多变量逻辑回归分析,对人口统计学因素和合并症进行调整,按组织学亚型、治疗、年龄和诊断年份分层,以分析原发性肺癌脑转移瘤患者的不良事件。诊断年份分为2013年之前/之后,以考虑治疗模式的变化。结果显示了细微的性别特异性不良事件。2013年后被诊断为小细胞、鳞状细胞或其他非小细胞癌脑转移瘤的女性比男性更容易出现头痛。2013年后患有腺癌的男性更有可能发生脑疝。与同龄男性相比,76岁及以上患有小细胞脑转移瘤的女性出现视力障碍的风险增加,其他年龄组无显著差异。接受腺癌治疗的男性面临更高的出血性中风风险。这项研究揭示了老年肺癌脑转移瘤患者不良事件中存在性别特异性差异,这些差异因组织学亚型、年龄、诊断年份和治疗而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/7aa70b2b94ac/cancers-16-02986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/aa9046963aeb/cancers-16-02986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/078c2eafe158/cancers-16-02986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/479d72a0f85f/cancers-16-02986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/d52c62e166b9/cancers-16-02986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/7aa70b2b94ac/cancers-16-02986-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/aa9046963aeb/cancers-16-02986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/078c2eafe158/cancers-16-02986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/479d72a0f85f/cancers-16-02986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/d52c62e166b9/cancers-16-02986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82e/11394199/7aa70b2b94ac/cancers-16-02986-g005.jpg

相似文献

1
Sex Difference in Disease-Related Adverse Events Post-Diagnosis of Lung Cancer Brain Metastases in Medicare Individuals ≥ 66 Years of Age.66岁及以上医疗保险参保个体肺癌脑转移诊断后疾病相关不良事件的性别差异
Cancers (Basel). 2024 Aug 28;16(17):2986. doi: 10.3390/cancers16172986.
2
Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.上消化道癌患者的脑转移与近端腺癌和淋巴结转移有关。
Gastric Cancer. 2020 Sep;23(5):904-912. doi: 10.1007/s10120-020-01075-3. Epub 2020 Apr 28.
3
Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.PET和MRI分期时代III期非小细胞肺癌脑转移的真实世界风险
Front Oncol. 2023 Mar 24;13:1139940. doi: 10.3389/fonc.2023.1139940. eCollection 2023.
4
Multicenter analysis of stereotactic radiosurgery for multiple brain metastases from EGFR and ALK driven non-small cell lung cancer.多中心分析 EGFR 和 ALK 驱动的非小细胞肺癌脑转移的立体定向放射外科治疗。
Lung Cancer. 2023 Feb;176:144-148. doi: 10.1016/j.lungcan.2022.11.019. Epub 2022 Dec 12.
5
Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.肺癌脑转移灶中 T 细胞免疫微环境的空间解析分析。
J Immunother Cancer. 2021 Oct;9(10). doi: 10.1136/jitc-2021-002684.
6
Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment.老年医疗保险患者(≥66 岁)在胶质母细胞瘤治疗后的不良事件中的性别差异。
J Neurooncol. 2024 May;168(1):111-123. doi: 10.1007/s11060-024-04652-z. Epub 2024 Apr 2.
7
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer.中枢神经系统降期:一种针对致癌基因成瘾性肺癌广泛脑转移的新兴治疗模式。
Lung Cancer. 2023 Apr;178:103-107. doi: 10.1016/j.lungcan.2023.02.006. Epub 2023 Feb 8.
8
Sex and gender differences in adverse events following influenza and COVID-19 vaccination.流感和 COVID-19 疫苗接种后不良事件的性别差异。
Biol Sex Differ. 2024 Jun 18;15(1):50. doi: 10.1186/s13293-024-00625-z.
9
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.非小细胞肺癌脑转移及可操作基因组改变患者的临床处理:系统文献回顾。
Adv Ther. 2024 May;41(5):1815-1842. doi: 10.1007/s12325-024-02799-9. Epub 2024 Mar 21.
10
Systemic treatment of brain metastases in non-small cell lung cancer.非小细胞肺癌脑转移的系统治疗。
Eur J Cancer. 2020 Jun;132:187-198. doi: 10.1016/j.ejca.2020.03.006. Epub 2020 May 4.

本文引用的文献

1
Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment.老年医疗保险患者(≥66 岁)在胶质母细胞瘤治疗后的不良事件中的性别差异。
J Neurooncol. 2024 May;168(1):111-123. doi: 10.1007/s11060-024-04652-z. Epub 2024 Apr 2.
2
Management of Brain Metastases: A Review of Novel Therapies.脑转移瘤的治疗管理:新疗法的综述。
Semin Neurol. 2023 Dec;43(6):845-858. doi: 10.1055/s-0043-1776782. Epub 2023 Nov 27.
3
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study.
2020 年按组织学亚型划分的全球肺癌发病率变化:一项基于人群的研究。
Lancet Oncol. 2023 Nov;24(11):1206-1218. doi: 10.1016/S1470-2045(23)00444-8. Epub 2023 Oct 11.
4
Sex Differences in Lung Cancer.肺癌中的性别差异
Cancers (Basel). 2023 Jun 8;15(12):3111. doi: 10.3390/cancers15123111.
5
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.靶向毒性:监测非小细胞肺癌治疗中使用的靶向治疗的不良反应的方案。
Int J Mol Sci. 2023 May 29;24(11):9429. doi: 10.3390/ijms24119429.
6
New Actions on Actionable Mutations in Lung Cancers.肺癌可操作突变的新进展
Cancers (Basel). 2023 May 26;15(11):2917. doi: 10.3390/cancers15112917.
7
Advances in the Molecular Landscape of Lung Cancer Brain Metastasis.肺癌脑转移分子格局的进展
Cancers (Basel). 2023 Jan 24;15(3):722. doi: 10.3390/cancers15030722.
8
Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer.非小细胞肺癌的脑实质和软脑膜转移。
Sci Rep. 2022 Dec 26;12(1):22372. doi: 10.1038/s41598-022-26131-z.
9
Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors.21 种癌症类型发病率的性别差异:危险因素贡献的量化。
Cancer. 2022 Oct 1;128(19):3531-3540. doi: 10.1002/cncr.34390. Epub 2022 Aug 8.
10
The Role of Testosterone in the Elderly: What Do We Know?睾酮在老年人中的作用:我们了解多少?
Int J Mol Sci. 2022 Mar 24;23(7):3535. doi: 10.3390/ijms23073535.